Stock Ratings / Consumer Staples / YI / financials

PETS (19) RDGT (37) GRDN (71) CVS (61) ⌘ Pro Terminal →

111 Inc. (YI) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

$2.85 -4.36% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.82

111 Inc. (YI) carries a Roarable Rating of D- (Sell) with 37/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $26.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on YI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is YI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, 111 Inc. (NASDAQ: YI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 37/100 at a spot price of $2.85 (-4.36% 1D, market cap $26.2M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 146 tracked Consumer Staples issuers, YI ranks #112 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does YI compare to PETS and RDGT in the Consumer Staples sector?

▼

Within the Consumer Staples sector (Retail-Drug Stores and Proprietary Stores), YI carries a Roarable D- (37/100 RQD), trailing P/E of N/A, gross margin of 5.8%, and ROIC of -20.5%. By comparison, PETS (PetMed Express Inc.) holds a E grade (19/100 RQD, P/E N/A, ROIC -35.0%, cap $25.6M) and RDGT (Ridgetech Inc.) posts a D- grade (37/100 RQD, P/E N/A, ROIC —, cap $3.0M). Among the 5-stock peer group, GRDN leads on earnings multiple (52.1x) while GRDN leads on capital efficiency (37.7% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for YI?

▼

Per YI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001738906), 111 Inc. generated $1.80B in revenue (-9.0% YoY), $0 in net income, and $16.4M in free cash flow against $314.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Staples with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.82 (-0.97%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 0.9% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (37/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.1% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-9.5% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for YI)Realized 20D OHLCV Swing Band: ±9.3%

Deterministic 5-Pillar Attribution (37/100 Composite)

🔍 WHY YI SCORES 37/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+12/20 pts (32% of score)

Altman Z-Score 3.34 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 3/9

▲ #2 Bullish Driver: Cash Engine Quality+9/20 pts (24% of score)

SEC XBRL FY 2025 (10-K): 0.9% FCF Margin ($16.4M FCF) & 5.8% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$3.11+1% Next Q

Q2 (-2Q)

Grade D$3.14-4.5% Next Q

Q3 (-1Q)

Grade D$3.00-5% Next Q

Current

Grade D-$2.85-8.1% Hist 90D α

Trajectory: D (45) → D- (37)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a YI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While YI currently carries a cautious 37/100 (D-) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Staples with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.30) and Max Pain ($2.99) forces dealer call-delta covering toward $11.73.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $YI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “YI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 37%NO 63%Trade / Inspect Odds →

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How YI Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$16.4M (0.9% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $2.11B

FY24

Rev $1.97B

FY25

Rev $1.80B

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$1.80B	5.8%	0%	$0	$16.4M	-45%
FY 2024	$1.97B	5.8%	0%	$0	$34.0M	95%
FY 2023	$2.11B	8%	-2.3%	$0	-$63.0M	-20.5%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring YI)

✓Walkthrough of YI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

YI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -51.86%📐 HORIZONTAL RANGE

2026-11-02O $2.97H $2.98L $2.85C $2.85VOL 100.4K

RES: $4.06SUP: $1.98SMA50: $3.30SMA200: $5.04

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

YI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 YI Butterfly Map → + Track YI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -9.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on YI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for YI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for YI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (YI)

Consumer Staples Rank #112 of 146 ⚔️ PETS vs YI Full Matrix →

1. Head-to-Head Consumer Staples Peer Comparison (YI vs. PETS, RDGT, GRDN, CVS)

Industry: Retail-Drug Stores and Proprietary Stores (5 Tracked Issuers)

Across 146 tracked Consumer Staples securities in the Roarable RQD universe, 111 Inc. (YI) ranks #112 by composite RQD confidence (37/100, grade D-) and #116 by equity capitalization ($26.2M). Within this direct 5-issuer industry benchmark cohort, GRDN leads on earnings valuation at 52.1x trailing P/E, while GRDN leads on capital efficiency and profitability with 37.7% ROIC and 20.2% gross margin. GRDN currently holds the highest overall quantitative score in the immediate peer group at 71/100 (B-) compared with YI at 37/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
YI ACTIVE 111 Inc.	D-	37/100	—	5.8%	-20.5%	-4.36%	$26.2M	Benchmark Subject
PETS PetMed Express Inc.	E	19/100	—	28.1%	-35.0%	+0.85%	$25.6M	/pets-vs-yi →
RDGT Ridgetech Inc.	D-	37/100	—	3.6%	—	-3.32%	$3.0M	/rdgt-vs-yi →
GRDN Guardian Pharmacy Services Inc. (Class A)	B-	71/100	52.1x	20.2%	37.7%	+0.59%	$2.56B	/grdn-vs-yi →
CVS CVS Health Corporation	C-	61/100	65.3x	45.0%	2.6%	-0.09%	$115.53B	/cvs-vs-yi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001738906

In its most recent audited fiscal period (FY2025, filed 2025-12-31), 111 Inc. (YI) reported GAAP revenue of $1.80B (-9.0% vs. FY2024 revenue of $1.97B , and -14.7% cumulative change since FY2023) , GAAP net income of $0, operating cash flow of $17.0M, and free cash flow of $16.4M (-51.7% YoY). On the balance sheet, YI closed FY2025 with $314.6M in total assets against $0 in total debt (Altman Z-Score: 3.34, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.80B	$0	$17.0M	$16.4M	$314.6M	—
FY2024 (FY)	2024-12-31	$1.97B	$0	$36.0M	$34.0M	$381.9M	—
FY2023 (FY)	2023-12-31	$2.11B	$0	-$63.0M	-$63.0M	—	—

3. YI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is YI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does YI compare to PETS and RDGT in the Consumer Staples sector?

What are the biggest fundamental strengths and SEC risk factors for YI?

Where is YI trading relative to its 50-day, 200-day, and 52-week technical levels?

YI last traded at $2.85 (-4.36% on volume of 21,640 shares), positioning the stock -13.64% below its 50-day simple moving average ($3.30) and -43.45% below its 200-day simple moving average ($5.04). Across its 52-week range of $2.48 to $11.17, YI sits at the 4.3% percentile with a 14-day RSI of 41.7 (NEUTRAL RANGE) and an implied next-earnings move of ±9.3% ($2.58 to $3.12).

YI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

How profitable is 111 Inc. (YI)?

In FY 2025 (10-K), YI converted $1.8B of revenue into a 5.8% gross margin, 0% operating margin, and $16.4M in free cash flow (0.9% FCF margin).

Direct Sub-Reports: YI RQD Cockpit YI 12M Forecast YI Earnings & Move YI Dividends & DRIP YI Insiders & 13F YI Whale Options YI Profit Sankey YI News & Why

ROARABLE RATING BRIEF • RQD 37/100 (D-) ✓ STAGE-C NUMBER FIREWALL VERIFIED

YI — 111 Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:49:14Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, 111 Inc. scores 37 out of 100 with a letter grade of D-, labeled "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars break down as follows. Fundamental cash engine scores 9 of 20, reflecting ROIC of -20.5% and FCF yield of 0%. Whale/13F flow scores 3 of 20, reflecting institutional accumulation and options positioning. Insider conviction scores 5 of 20, reflecting SEC Form 4 and Congressional PTR cluster flow. Macro regime fit scores 8 of 20, reflecting beta of 1.0 and sector sensitivity. Forensic balance sheet scores 12 of 20, reflecting Altman Z of 3.34, Piotroski F of 3/9, and Debt/Equity of 0.5.

For a prospective investor, the weakest pillars are the cash engine and institutional flow, and the strongest is the balance sheet. The balance sheet score suggests the company is not in immediate distress by the cited Altman and Debt/Equity measures, but the negative ROIC and zero FCF yield indicate the operating business is not currently generating returns on capital. The low whale-flow score means the source data does not show meaningful institutional support to offset that weakness. Upside drivers would need to come from a change in operating returns or a catalyst the data does not quantify; valuation tradeoffs at a $2.98 price with a $26.2M market cap rest on whether the market is pricing a turnaround or a continued decline.

Business

Per the profile, 111 Inc. (YI) is a NASDAQ-listed issuer in the Consumer Staples sector, specifically the Retail-Drug Stores and Proprietary Stores industry. The profile does not describe its products, customers, or revenue model. Per the SEC financials, the company reported revenue of $1795.5M for FY 2025. Gross margin is listed as 5.8% in the market data, with operating and net margins at 0%.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$1795.5M	$-0.3M	$0.0M	N/A	$16.4M	$73.1M	N/A
FY 2024	$1973.0M	$0.3M	$0.0M	N/A	$34.0M	$63.3M	N/A
FY 2023	$2105.4M	$-49.3M	$0.0M	N/A	$-63.0M	N/A	N/A

Per the SEC financials, revenue declined in each reported period, from $2105.4M to $1973.0M to $1795.5M. Operating income moved from $-49.3M to $0.3M to $-0.3M, and net income is reported as $0.0M across all three periods. Per the Roarable RQD rating, ROIC is -20.5%, the Altman Z-Score is 3.34, and the Piotroski F-Score is 3/9. Debt/Equity is cited as 0.5 in the rating, while the debt line in the financials is N/A.

Recent Catalysts & News Wire Analysis

Per the recent news feed, five items reference YI. Headlines indicate that a special committee has been formed and is reviewing strategic options and a buyout proposal, and that the company has appointed an independent financial advisor and legal counsel to that committee. Each item is marked with a YELLOW light and a MARKET WIRE impact label. A TradingView item and a siam.in item reference market action and buying pressure without quantified detail. The feed does not disclose proposal terms, pricing, or timing. Per the Butterfly Supply-Chain Graph, the supply chain is listed as NONE, with no butterfly links and no proprietary signals.

Open Questions

What are the terms, pricing, and timing of the buyout proposal reviewed by the special committee?
What drives the reported revenue decline across FY 2023 to FY 2025, and what is the path back to positive ROIC?
Why is the debt figure reported as N/A in the financials while Debt/Equity of 0.5 appears in the rating?
What products and customers generate the company's revenue, given the profile lacks a business description?
Why are EPS and valuation multiples unavailable, and how does that affect comparison against peers?

YI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for 111 Inc. (YI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to YI Debate Forum (3) ↓

🟡 MARKET WIRE TradingView • 7h ago

111, Inc. Estimates – NASDAQ:YI

TradingView report covering 111 Inc. (YI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 10h ago

111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee

Yahoo Finance report covering 111 Inc. (YI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE ad-hoc-news.de • 13h ago

111 forms special committee and reviews strategic options for 111 stock

ad-hoc-news.de report covering 111 Inc. (YI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE www.siam.in • 16h ago

American (YI) Advances +2.42% as Buying Pressure Builds 2026-10-18 - Elliott Wave Entry

www.siam.in report covering 111 Inc. (YI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE ad-hoc-news.de • 19h ago

111 forms special committee to review buyout proposal for 111 stock

ad-hoc-news.de report covering 111 Inc. (YI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 35d ago

111, Inc. Announces Establishment of the Special Committee

111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), comprising of three independent directo

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 46d ago

111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company

111 Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, today announced that its Board of Directors (the "Board") has received an unsolicited preliminary non-binding

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 143d ago

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Marginally Lower for Week

Asian equities traded in the US as American depositary receipts were tracking higher Friday morning,

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

YI Bull vs. Bear Conversation Board — What's Your Call at $2.85?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON YI 🐻 67% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $2.62 (-12.1%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is YI (D- • RQD 37/100) a Buy at $2.98?

Welcome to the YI (111 Inc.) Roar Pit. Current RQD Composite is 37/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Retail-Drug Stores and Proprietary Stores. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

BE BearTrap_Alert Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $2.32 (-22.1%)

Spot @ $2.98

Pump the brakes on YI — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on YI, but look at what you are paying: current EV/EBITDA multiples with 5.8% gross margins. Unless 111 Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

CA CashFlowKing Verified K Arena Trader 🐂 BULLISH 🎯 Target: $3.73 (+25.2%)

Spot @ $2.98

YI cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on YI, the market is fixating on short-term headline noise in Retail-Drug Stores and Proprietary Stores and ignoring the balance sheet and cash flow trajectory. At $2.98 (52-wk range $2.48 - $11.17), any beat on forward guidance forces shorts and underweight funds to chase.